Human medicines European public assessment report (EPAR): Zydelig, idelalisib, Revision: 14, Authorised

09:10 EDT 3 Aug 2018 | European Medicines Agency

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Zydelig, idelalisib, Revision: 14, Authorised"